Up to ten years of visual acuity outcomes in fellow eyes post-uveal melanoma treatment with iodine-125 radiotherapy, transpupillary thermotherapy, and proton beam therapy
This study suggests that following uveal melanoma treatment with either <sup>125</sup>I PRT, TTT, or PBT, fellow eyes remain stable regarding VA and other outcomes up to 10 years. This provides important information for treatment choice in patients with ocular melanoma, especially as VA can decline in affected eye post-treatment, leading to reliance on contralateral eye.
Authors
- Amy Jasani
- Gerald McGwin (ORCID: https://orcid.org/0000-0001-9592-1133)
- John O. Mason (ORCID: https://orcid.org/0000-0002-0076-142X)
- LeAnn B. Norris (ORCID: https://orcid.org/0000-0001-7656-1259)
Institutions
- University of Alabama at Birmingham (US)
- Retina Consultants of Texas (US)
Publication Details
- Journal
- Journal of Contemporary Brachytherapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/jcb.2025.152469
- Citations
- 1
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71